Monday, October 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· November 10, 2025

Stock market today: S&P 500, Nasdaq soar, lead Dow higher as Senate vote lifts hopes for end to US shutdown

View original at finance.yahoo.com
Stock market today: S&P 500, Nasdaq soar, lead Dow higher as Senate vote lifts hopes for end to US shutdown Tech stocks led a roaring start to Wall Street's week, with investor spirits boosted by Congress taking a big step toward ending the record-breaking government shutdown that has clouded the picture of the economy…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The extraordinary list of accomplishments achieved in the past few months tells the story of Venture Global's unwavering commitment to streamline high-impact execution in its growth to date

    80% confidence
  • US capacity for natural gas liquefaction is expected to more than double by 2029

    80% confidence
  • S&P 500 will reach 7,500 by the end of 2026, fueled by strong corporate earnings and gains in resilient technology sector

    80% confidence
  • There are clear signs an earnings recovery is underway that will fuel a stock rally next year

    80% confidence
  • A lot of liquidity pulled out of the market since August peaks, sentiment soured, and government shutdown brought malaise that turned market tenderness into vulnerability

    80% confidence
  • North American exports of LNG are expected to more than double over the same period

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com